Return On Equity in % of Checkpoint Therapeutics, Inc. from Q2 2017 to Q1 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Checkpoint Therapeutics, Inc. quarterly/annual Return On Equity history and change rate from Q2 2017 to Q1 2025.
  • Checkpoint Therapeutics, Inc. Return On Equity for the quarter ending 31 Mar 2025 was 916 %, a 187% increase year-over-year.
  • Checkpoint Therapeutics, Inc. annual Return On Equity for 2024 was 439 %, a 64.2% increase from 2023.
  • Checkpoint Therapeutics, Inc. annual Return On Equity for 2023 was 267 %.
  • Checkpoint Therapeutics, Inc. annual Return On Equity for 2022 was -3.65K %, a 2941% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Checkpoint Therapeutics, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q1 2025 916 +597 +187% 01 Jan 2025 31 Mar 2025
Q4 2024 439 +172 +64.2% 01 Oct 2024 31 Dec 2024
Q3 2024 360 +104 +40.6% 01 Jul 2024 30 Sep 2024
Q2 2024 292 -61.5 -17.4% 01 Apr 2024 30 Jun 2024
Q1 2024 319 -314 -49.6% 01 Jan 2024 31 Mar 2024
Q4 2023 267 +3.92K 01 Oct 2023 31 Dec 2023
Q3 2023 256 +765 01 Jul 2023 30 Sep 2023
Q2 2023 354 +627 01 Apr 2023 30 Jun 2023
Q1 2023 633 +806 01 Jan 2023 31 Mar 2023
Q4 2022 -3.65K -3.53K -2941% 01 Oct 2022 31 Dec 2022
Q3 2022 -509 -432 -566% 01 Jul 2022 30 Sep 2022
Q2 2022 -273 -206 -305% 01 Apr 2022 30 Jun 2022
Q1 2022 -173 -98.4 -132% 01 Jan 2022 31 Mar 2022
Q4 2021 -120 -30.3 -33.7% 01 Oct 2021 31 Dec 2021
Q3 2021 -76.4 +24.1 +24% 01 Jul 2021 30 Sep 2021
Q2 2021 -67.5 +88.5 +56.8% 01 Apr 2021 30 Jun 2021
Q1 2021 -74.8 +107 +59% 01 Jan 2021 31 Mar 2021
Q4 2020 -89.8 +161 +64.2% 01 Oct 2020 31 Dec 2020
Q3 2020 -101 +239 +70.4% 01 Jul 2020 30 Sep 2020
Q2 2020 -156 +107 +40.7% 01 Apr 2020 30 Jun 2020
Q1 2020 -182 +29.8 +14.1% 01 Jan 2020 31 Mar 2020
Q4 2019 -251 -79.8 -46.6% 01 Oct 2019 31 Dec 2019
Q3 2019 -340 -201 -145% 01 Jul 2019 30 Sep 2019
Q2 2019 -263 -136 -108% 01 Apr 2019 30 Jun 2019
Q1 2019 -212 -89.8 -73.5% 01 Jan 2019 31 Mar 2019
Q4 2018 -171 -68.7 -67.1% 01 Oct 2018 31 Dec 2018
Q3 2018 -139 -44.2 -46.6% 01 Jul 2018 30 Sep 2018
Q2 2018 -127 -46.7 -58.5% 01 Apr 2018 30 Jun 2018
Q1 2018 -122 01 Jan 2018 31 Mar 2018
Q4 2017 -102 01 Oct 2017 31 Dec 2017
Q3 2017 -94.8 01 Jul 2017 30 Sep 2017
Q2 2017 -79.9 01 Apr 2017 30 Jun 2017

Checkpoint Therapeutics, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 439 +172 +64.2% 01 Jan 2024 31 Dec 2024
2023 267 +3.92K 01 Jan 2023 31 Dec 2023
2022 -3.65K -3.53K -2941% 01 Jan 2022 31 Dec 2022
2021 -120 -30.3 -33.7% 01 Jan 2021 31 Dec 2021
2020 -89.8 +161 +64.2% 01 Jan 2020 31 Dec 2020
2019 -251 -79.8 -46.6% 01 Jan 2019 31 Dec 2019
2018 -171 -68.7 -67.1% 01 Jan 2018 31 Dec 2018
2017 -102 01 Jan 2017 31 Dec 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.